BSE Live
Oct 31, 16:01Prev. Close
30.23
Open Price
30.23
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Profit & Loss account of Genomic Valley Biotech (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 0.84 | 0.17 | 2.72 | 0.07 | 0.21 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 0.84 | 0.17 | 2.72 | 0.07 | 0.21 | |
| Total Operating Revenues | 0.84 | 0.17 | 2.72 | 0.07 | 0.21 | |
| Other Income | 0.00 | 0.00 | 0.04 | 0.08 | 0.00 | |
| Total Revenue | 0.85 | 0.17 | 2.77 | 0.15 | 0.21 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |
| Purchase Of Stock-In Trade | 0.49 | 0.00 | 1.58 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -0.28 | 0.00 | 0.00 | 0.00 | 0.08 | |
| Employee Benefit Expenses | 0.12 | 0.04 | 0.15 | 0.14 | 0.09 | |
| Finance Costs | 0.00 | 0.00 | 0.00 | 0.04 | 0.18 | |
| Depreciation And Amortisation Expenses | 0.00 | 0.00 | 0.01 | 0.08 | 0.19 | |
| Other Expenses | 0.08 | 0.11 | 0.11 | 0.31 | 0.18 | |
| Total Expenses | 0.41 | 0.15 | 1.85 | 0.58 | 0.71 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 0.44 | 0.02 | 0.91 | -0.42 | -0.50 | |
| Exceptional Items | 0.00 | 0.00 | -0.26 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 0.44 | 0.02 | 0.65 | -0.42 | -0.50 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.01 | 0.06 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 0.09 | 0.00 | 0.00 | 0.01 | 0.06 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 0.36 | 0.02 | 0.65 | -0.43 | -0.56 | |
| Profit/Loss From Continuing Operations | 0.36 | 0.02 | 0.65 | -0.01 | -0.56 | |
| Profit/Loss For The Period | 0.36 | 0.02 | 0.65 | -0.01 | -0.56 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 1.17 | 0.05 | 2.12 | -0.03 | -1.83 | |
| Diluted EPS (Rs.) | 1.17 | 0.05 | 2.12 | -0.03 | -1.83 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
16.10.2025
Genomic Valley Standalone September 2025 Net Sales at Rs 0.09 crore, down 56.1% Y-o-Y
19.08.2025
Genomic Valley Standalone June 2025 Net Sales at Rs 0.09 crore, down 42.05% Y-o-Y
21.10.2024
Genomic Valley Standalone September 2024 Net Sales at Rs 0.21 crore, up 203.61% Y-o-Y
30.07.2024
Genomic Valley Standalone June 2024 Net Sales at Rs 0.16 crore, up 165.24% Y-o-Y
16.10.2025
Genomic Valley Standalone September 2025 Net Sales at Rs 0.09 crore, down 56.1% Y-o-Y
19.08.2025
Genomic Valley Standalone June 2025 Net Sales at Rs 0.09 crore, down 42.05% Y-o-Y
21.10.2024
Genomic Valley Standalone September 2024 Net Sales at Rs 0.21 crore, up 203.61% Y-o-Y
30.07.2024
Genomic Valley Standalone June 2024 Net Sales at Rs 0.16 crore, up 165.24% Y-o-Y